With the development of thermal cyclers incorporating fluorescent detection, the polymerase chain reaction assay (PCR)has new, innovative applications. In routine PCR, the critical result is the final quantity of amplicon generated from the assay. Quantitative PCR, or real-time PCR, (qPCR) and reverse transcription PCR (RT-PCR) use the linearity of DNA amplification to determine absolute or relative quantities of a known sequence in a sample. By using a fluorescent reporter in the reaction, it is possible to measure DNA generation in the qPCR assay.

Request for Free Sample Copy of this Research Report at: https://www.vynzresearch.com/healthcare/qpcr-reagents-market/request-sample

The global qPCR reagents market is growing at a significant rate due to the mounting occurrence of infectious diseases and genetic disorders, technological improvement and speedy progression in the geriatric population. The market has witnessed a high demand for qPCR core kits over the last few years, due to low prices of core kits.

Key players in the qPCR reagents industry are investing in the development of innovative and advance quantitative polymerase chain reaction reagents products, which is strengthening their position in the market. Thermo Fisher Scientific, Bio-Rad Laboratories Inc., and Qiagen N.V. together accounted the major share of the qPCR reagents market. For instance, In March 2018, Thermo Fisher Scientific Inc., acquired IntegenX Inc., to enhance its product portfolio. IntegenX Inc, is a company which offers a speedy DNA platform for use in forensics and law implementation applications.

Insight by Detection Method

There are two types of detection methods for qPCR reagents, dye-based, and probes and primer-based. Both probe and primer based detection method is expected to grow at the high pace in the market due to its benefits over the dye-based such as more exact than dye based.

Insight by Packaging Type

On the basis of packaging type, the qPCR reagents market is subdivided into qPCR core kits and qPCR master mixes. qPCR core kit have the largest share in the market due to boosting market accessibility of core kits across major countries, minimal prices of core kits, growing private-public finance for life science research, and suppleness offered to end users.

Insight by Application

The global qPCR reagents market has also been further divided by application into diagnostic applications, research applications & forensic applications. The forensic application is expected to grow at a significant rate in the market due to mounting frequencies of criminal cases, and boosting laboratory automation in forensic laboratories.

In addition, in April 2018, QIAGEN N.V. launched QIAstat-Dxâ an integrated molecular analysis of common syndromes as tested for in syndromes in infections, oncology and other diseases in Europe. Thermo Fisher Scientific Inc., Affymetrix, Inc., Bio-Rad Laboratories, Inc., Takara Bio Inc., F. Hoffman-La Roche Ltd., Promega Corporation, Qiagen N.V., Agilent Technologies, Inc., Sigma-Aldrich Corporation, and Quanta Biosciences, Inc. are some of the key players offering qPCR reagents products.

Source: VynZ Research